ZA868162B - Pharmaceutically active phosphino-hydrocarbon-group viii-metal complexes,antitumor compositions containing these complexes,and a process for preparing said compounds or antitumor compositions - Google Patents

Pharmaceutically active phosphino-hydrocarbon-group viii-metal complexes,antitumor compositions containing these complexes,and a process for preparing said compounds or antitumor compositions

Info

Publication number
ZA868162B
ZA868162B ZA868162A ZA868162A ZA868162B ZA 868162 B ZA868162 B ZA 868162B ZA 868162 A ZA868162 A ZA 868162A ZA 868162 A ZA868162 A ZA 868162A ZA 868162 B ZA868162 B ZA 868162B
Authority
ZA
South Africa
Prior art keywords
sub
compounds
complexes
antitumor compositions
hydrocarbon
Prior art date
Application number
ZA868162A
Other languages
English (en)
Inventor
Klaas Timmer
Harmen Anne Meinema
John Eberhard Schurig
Original Assignee
Tno
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tno filed Critical Tno
Publication of ZA868162B publication Critical patent/ZA868162B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0033Iridium compounds
    • C07F15/004Iridium compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/006Palladium compounds
    • C07F15/0066Palladium compounds without a metal-carbon linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0073Rhodium compounds
    • C07F15/008Rhodium compounds without a metal-carbon linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086Platinum compounds
    • C07F15/0093Platinum compounds without a metal-carbon linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02Iron compounds
    • C07F15/025Iron compounds without a metal-carbon linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/04Nickel compounds
    • C07F15/045Nickel compounds without a metal-carbon linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/06Cobalt compounds
    • C07F15/065Cobalt compounds without a metal-carbon linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA868162A 1985-10-25 1986-10-27 Pharmaceutically active phosphino-hydrocarbon-group viii-metal complexes,antitumor compositions containing these complexes,and a process for preparing said compounds or antitumor compositions ZA868162B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8502929A NL8502929A (nl) 1985-10-25 1985-10-25 Groep viii-overgangsmetaal-complexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een geneesmiddel met toepassing van een dergelijke groep viii-overgangsmetaal-complex voor de behandeling van kanker, alsmede aldus verkregen gevormd geneesmiddel.

Publications (1)

Publication Number Publication Date
ZA868162B true ZA868162B (en) 1987-06-24

Family

ID=19846766

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA868162A ZA868162B (en) 1985-10-25 1986-10-27 Pharmaceutically active phosphino-hydrocarbon-group viii-metal complexes,antitumor compositions containing these complexes,and a process for preparing said compounds or antitumor compositions

Country Status (21)

Country Link
US (1) US4831170A (zh)
EP (1) EP0227127B1 (zh)
JP (1) JPS62161795A (zh)
KR (1) KR870003787A (zh)
CN (3) CN86107219A (zh)
AT (1) ATE63122T1 (zh)
AU (1) AU601954B2 (zh)
CA (1) CA1269395A (zh)
DE (1) DE3679045D1 (zh)
DK (1) DK511786A (zh)
ES (1) ES2039199T3 (zh)
FI (1) FI85861C (zh)
GR (1) GR3001910T3 (zh)
HU (2) HU203557B (zh)
IL (1) IL80416A0 (zh)
NL (1) NL8502929A (zh)
NO (1) NO172585B (zh)
NZ (1) NZ218072A (zh)
PT (1) PT83612B (zh)
YU (1) YU45802B (zh)
ZA (1) ZA868162B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1378240T3 (da) * 1997-10-15 2008-12-08 Polarx Biopharmaceuticals Inc Farmaceutiske præparater omfattende arsentrioxid til behandling af multipelt myelom
JP5015451B2 (ja) * 2005-04-18 2012-08-29 日本化学工業株式会社 ホスフィン遷移金属錯体、その製造方法およびそれを含有する抗癌剤
WO2009081366A1 (en) * 2007-12-20 2009-07-02 Richard John Bowen Palladium and platinum phosphine complexes and their use as anti-tumour agents
WO2009104167A1 (en) * 2008-02-22 2009-08-27 Mintek A substance or composition for the treatment of cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3084179A (en) * 1959-02-27 1963-04-02 Ici Ltd Phosphorous-containing-ligand stabilized transition metal compounds
US3345392A (en) * 1964-03-24 1967-10-03 American Cyanamid Co Organophosphorus-copper complex compounds
GB1085762A (en) * 1965-04-30 1967-10-04 Ici Ltd Complex organic iridium compounds and their use as catalysts
FR2116905A5 (fr) * 1970-12-10 1972-07-21 Inst Francais Du Petrole Nouveaux coordinats bidentes,leur fabrication et leurs applications
US3939188A (en) * 1972-03-24 1976-02-17 Exxon Research And Engineering Company Preparation of zerovalent phosphine substituted rhodium compounds and their use in the selective carbonylation of olefins
US3954821A (en) * 1975-06-30 1976-05-04 E. I. Du Pont De Nemours And Company Carbon dioxide complexes of Rh, Ir, Ni, Pd, and Pt
US4268454A (en) * 1978-12-21 1981-05-19 Allied Chemical Corporation Anionic group VIII metal hydride catalysts
US4302401A (en) * 1980-01-23 1981-11-24 Exxon Research & Engineering Co. Tetraalkyl phosphonium substituted phosphine and amine transition metal complexes
US4331818A (en) * 1980-03-19 1982-05-25 The Procter & Gamble Company Chiral phospine ligand
CA1238854A (en) * 1984-02-01 1988-07-05 David T. Hill ANTITUMOR PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING TUMORS EMPLOYING ¬.alpha.,W- BIS(DISUBSTITUTEDPHOSPHINO)HYDROCARBON| DIGOLD (I) DIGOLD (III), DISILVER (I) AND DICOPPER (I) DERIVATIVES
PH21350A (en) * 1984-06-04 1987-10-13 Smithkline Beckman Corp Tumor cell growth imhibiting pharmaceutical compositions containing phosphino-hydrocarbon-gold, silver or copper complexes

Also Published As

Publication number Publication date
PT83612A (en) 1986-11-01
AU601954B2 (en) 1990-09-27
HUT44263A (en) 1988-02-29
NO864270L (no) 1987-04-27
YU45802B (sh) 1992-07-20
IL80416A0 (en) 1987-01-30
HU203557B (en) 1991-08-28
CA1269395A (en) 1990-05-22
GR3001910T3 (en) 1992-11-23
DK511786A (da) 1987-04-26
JPS62161795A (ja) 1987-07-17
NO864270D0 (no) 1986-10-24
EP0227127A3 (en) 1988-09-07
NO172585B (no) 1993-05-03
CN1067430A (zh) 1992-12-30
FI864327A0 (fi) 1986-10-24
EP0227127A2 (en) 1987-07-01
NZ218072A (en) 1990-12-21
ATE63122T1 (de) 1991-05-15
ES2039199T3 (es) 1993-09-16
FI85861B (fi) 1992-02-28
FI85861C (fi) 1992-06-10
NL8502929A (nl) 1987-05-18
DK511786D0 (da) 1986-10-24
YU181786A (en) 1988-02-29
AU6441386A (en) 1987-05-21
CN1057962A (zh) 1992-01-22
US4831170A (en) 1989-05-16
FI864327A (fi) 1987-04-26
CN86107219A (zh) 1987-05-27
EP0227127B1 (en) 1991-05-02
HU903471D0 (en) 1990-12-28
KR870003787A (ko) 1987-05-04
HU200609B (en) 1990-07-28
PT83612B (pt) 1989-05-31
DE3679045D1 (de) 1991-06-06

Similar Documents

Publication Publication Date Title
ES8102546A1 (es) Procedimiento para la preparacion de acetaldehido
EP0227127A3 (en) Pharmaceutically active phosphino-hydrocarbon-group viii-metal complexes, antitumor compositions containing these complexes, and a process for preparing said compounds or antitumor compositions
GB1458744A (en) Process for producing a 6-deoxytetracylines
DE2960376D1 (en) Process for preparing stereoisomeric n-aralkyl-2,6-dimethylmorpholines
IL89501A0 (en) Platinum derivatives,pharmaceutical compositions containing the same and a process for the preparation thereof
GB1511841A (en) Catalysis
ES8306765A1 (es) "un procedimiento para preparar un derivado de antraciclina".
ES8601802A1 (es) Un metodo de sintetizar un silicofosfoaluminato cristalino
ES470383A1 (es) Un metodo de preparacion de un derivado de 9-hidroxietoxime-til-guanina
GB1478825A (en) Process for the production of benzylamine and dibenzylamine
ES8503357A1 (es) Un procedimiento para la preparacion de glicosidos de antraciclina
IE46122L (en) Antitumour glycosides
IE40506L (en) Producing heterocyclic compounds.
GB1449070A (en) Aminotetralins and use in inducing anesthesia
ZA846783B (en) Nitrosourea derivatives,process for their preparation and pharmaceuticals containing them
JPS5236617A (en) Process for preparation of formamide derivatives
GB1387511A (en) Method for the preparation of hydrogen peroxide
GB1481891A (en) Derivatives of 1-alpha-naphthylsulphinyl-2-propanol
UA16971A1 (uk) Цис-діхлоромоhоаквоадеhозиhплатиhа /іі/ дигідрат, що виявляє протипухлиhhу активhість
IE40226L (en) 5-AMINOMETHYL-m-DIOXANES.
GB1507976A (en) Catalysis
ES452594A1 (es) Procedimiento de preparacion de cetonas.
GB1129437A (en) New urea derivatives, process for their preparation, and therapeutic composition containing same